Jason Okazaki, Assembly Bio's new CEO

Af­ter pre­sid­ing over stormy years, John McHutchi­son picks his 's­trate­gic part­ner' to run As­sem­bly Bio

Through­out the string of neg­a­tive news com­ing out of As­sem­bly Bio, CEO John McHutchi­son held on to the hope that his team of an­tivi­ral ex­perts would de­liv­er a func­tion­al cure for he­pati­tis B. Even as the biotech scrapped its lead drug, he point­ed to the promise of next-gen­er­a­tion pro­grams — while ex­pand­ing the scope of re­search to oth­er vi­ral tar­gets.

But he’s now putting the big turn­around play in a lieu­tenant’s hands.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.